Literature DB >> 28757264

Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.

Yuval A Patel1, Joanne C Imperial2, Andrew J Muir1, Quentin M Anstee3, David DeBrota4, Lara Dimick-Santos5, Claudia Filozof6, Ruby Mehta5, Arun J Sanyal7, Elmer Schabel8, Brent A Neuschwander-Tetri9, Veronica Miller10.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28757264      PMCID： PMC5861348          DOI： 10.1053/j.gastro.2017.07.024

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  25 in total

1.  Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.

Authors:  E Breda; M K Cavaghan; G Toffolo; K S Polonsky; C Cobelli
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

Review 2.  The forum for collaborative HIV research: a model for an integrated and inclusive approach to clinical research and drug development.

Authors:  V Miller
Journal:  Clin Pharmacol Ther       Date:  2009-07-29       Impact factor: 6.875

3.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

4.  Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Winston Dunn; Arun J Sanyal; Elizabeth M Brunt; Aynur Unalp-Arida; Michael Donohue; Arthur J McCullough; Jeffrey B Schwimmer
Journal:  J Hepatol       Date:  2012-04-17       Impact factor: 25.083

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 6.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

7.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

Review 8.  Nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Vincent W-S Wong; Valerio Nobili; Christopher P Day; Silvia Sookoian; Jacquelyn J Maher; Elisabetta Bugianesi; Claude B Sirlin; Brent A Neuschwander-Tetri; Mary E Rinella
Journal:  Nat Rev Dis Primers       Date:  2015-12-17       Impact factor: 52.329

Review 9.  Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime.

Authors:  J J Blonsky; S A Harrison
Journal:  Aliment Pharmacol Ther       Date:  2008-02-29       Impact factor: 8.171

10.  Racial differences in nonalcoholic fatty liver disease in the U.S. population.

Authors:  Andrea L C Schneider; Mariana Lazo; Elizabeth Selvin; Jeanne M Clark
Journal:  Obesity (Silver Spring)       Date:  2013-06-11       Impact factor: 5.002
View more
  3 in total

Review 1.  Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.

Authors:  Arie Regev; Melissa Palmer; Mark I Avigan; Lara Dimick-Santos; William R Treem; John F Marcinak; Daniel Seekins; Gopal Krishna; Frank A Anania; James W Freston; James H Lewis; Arun J Sanyal; Naga Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2019-02-13       Impact factor: 8.171

Review 2.  Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications.

Authors:  Katherine Martin; Anas Hatab; Varinder S Athwal; Elliot Jokl; Karen Piper Hanley
Journal:  Curr Diab Rep       Date:  2021-02-05       Impact factor: 4.810

3.  Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system.

Authors:  Ysabel C Ilagan-Ying; Jin Xu; Joseph K Lim; Albert Do
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-03-01       Impact factor: 2.586
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.